Epilepsy Foundation of America - The FDA recently approved cenobamate (XCOPRI) for the treatment of focal aware seizures in adults. Learn more about cenobamate: https://bit.ly/3nI7iqR | Facebook
Paladin Labs Announces Health Canada's Filing Acceptance of Cenobamate Tablets as an Adjunctive Therapy for the Management of
Information for Colorado Prescribers of Prescription Drugs XCOPRI® (cenobamate tablets) CV • The following information is be
![SK Life Sciences' XCOPRI (cenobamate tablets) Receives the US FDA's Approval for Partial-Onset Seizures in Adults SK Life Sciences' XCOPRI (cenobamate tablets) Receives the US FDA's Approval for Partial-Onset Seizures in Adults](https://www.pharmashots.com/public/images/20211116000717_ogImage_20.png)